Lundbeck Is Said to Express Interest in Buying Xeris Biopharma

H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.